— Know what they know.
Not Investment Advice

LFSC

F/M Emerald Life Sciences Innovation ETF
1W: -2.4% 1M: -5.6% 3M: -6.4% YTD: +19.8% 1Y: +47.1%
$43.40
-0.05 (-0.13%)
 
Weekly Expected Move ±2.7%
$41 $42 $43 $45 $46
ETF NASDAQ · AUM $115.9M
Key Statistics
AUM$116M
Holdings39
Top 10 Wt52.1%
Volume2,391
Avg Volume4,262
Beta0.91
Portfolio Fundamentals
P/E95.7
P/B8.6
Div Yield—%
ROE-15.6%
% Profitable32%
Inception2024-10-21
Sector Allocation
Healthcare 99.5%
Financial Services 0.6%
Other -0.0%
Top 10 Holdings
# Name Ticker Weight % Market Value Shares
1 Corcept Therapeutics Inc CORT 7.05% $8.7M 75,436
2 Travere Therapeutics Inc TVTX 6.69% $8.3M 140,245
3 LivaNova PLC LIVN 6.54% $8.1M 105,381
4 Cogent Biosciences Inc COGT 6.11% $7.6M 235,467
5 Spyre Therapeutics Inc SYRE 5.16% $6.3M 71,476
6 Billiontoone Inc BLLN 4.67% $6.0M 54,115
7 Guardant Health Inc GH 4.41% $5.5M 30,504
8 Replimune Group Inc REPL 4.38% $5.5M 408,338
9 VeraDermics Inc MANE 3.64% $4.5M 37,030
10 Mirum Pharmaceuticals Inc MIRM 3.44% $4.3M 49,574

Recent Holding Changes

Date Holding Change Details
2026-09-25 SYRE Changed 79500 → 71476
2026-09-25 VCEL New —
2026-09-25 LMRI Removed —
2026-09-25 TMDX Changed 43617 → 50164
2026-09-25 OBIL Changed 265 → 2265

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms